Identification of novel gene amplifications in breast cancer and coexistence of gene amplification with an activating mutation of PIK3CA.
暂无分享,去创建一个
Mitsutaka Kadota | Maxwell P Lee | Junya Fukuoka | Barbara K Dunn | Maxwell P. Lee | Howard H. Yang | Sheryl Gere | L. Wakefield | A. Ooshima | M. Kadota | Misako Sato | S. Kageyama | B. Dunn | T. Nagata | J. Fukuoka | B. Duncan | N. Diaz-Meyer | K. Tsukada | Kazuhiro Tsukada | Shun-Ichiro Kageyama | Akira Ooshima | Howard H Yang | Misako Sato | Takuya Nagata | Lalage M Wakefield | Beverly Duncan | Natacha Diaz-Meyer | Sheryl Gere | M. Lee
[1] Joshy George,et al. Genetic reclassification of histologic grade delineates new clinical subtypes of breast cancer. , 2006, Cancer research.
[2] L. Hudson,et al. Enhanced Modulation of Keratinocyte Motility by Transforming Growth Factor-α (TGF-α) Relative to Epidermal Growth Factor (EGF) , 1996 .
[3] L. Holmberg,et al. Gene expression profiling spares early breast cancer patients from adjuvant therapy: derived and validated in two population-based cohorts , 2005, Breast Cancer Research.
[4] J. Ptak,et al. High Frequency of Mutations of the PIK3CA Gene in Human Cancers , 2004, Science.
[5] Xin Huang,et al. Somatic mutation and gain of copy number of PIK3CA in human breast cancer , 2005, Breast Cancer Research.
[6] Cun-Yu Wang,et al. TBL1–TBLR1 and β-catenin recruit each other to Wnt target-gene promoter for transcription activation and oncogenesis , 2008, Nature Cell Biology.
[7] K. Buetow,et al. Chromatin Remodeling Factors and BRM/BRG1 Expression as Prognostic Indicators in Non-Small Cell Lung Cancer , 2004, Clinical Cancer Research.
[8] K. Kinzler,et al. Cancer genes and the pathways they control , 2004, Nature Medicine.
[9] Stuart Brown,et al. TBLR1 regulates the expression of nuclear hormone receptor co-repressors , 2006, BMC Cell Biology.
[10] A. Sparks,et al. The Genomic Landscapes of Human Breast and Colorectal Cancers , 2007, Science.
[11] Barbara J. Trask,et al. Array Comparative Genomic Hybridization Analysis of Genomic Alterations in Breast Cancer Subtypes , 2004, Cancer Research.
[12] A. Moorman,et al. Patterning the embryonic heart: identification of five mouse Iroquois homeobox genes in the developing heart. , 2000, Developmental biology.
[13] Daniel Birnbaum,et al. Integrated profiling of basal and luminal breast cancers. , 2007, Cancer research.
[14] N. Crawford,et al. Bromodomain 4 activation predicts breast cancer survival , 2008, Proceedings of the National Academy of Sciences.
[15] J. Foekens,et al. Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer , 2005, The Lancet.
[16] Li Li,et al. High‐resolution genomic and expression analyses of copy number alterations in breast tumors , 2008, Genes, chromosomes & cancer.
[17] L. Wakefield,et al. TGF-β switches from tumor suppressor to prometastatic factor in a model of breast cancer progression , 2003 .
[18] D. Hanahan,et al. The Hallmarks of Cancer , 2000, Cell.
[19] Ash A. Alizadeh,et al. Genome-wide analysis of DNA copy-number changes using cDNA microarrays , 1999, Nature Genetics.
[20] Ajay N. Jain,et al. Genomic and transcriptional aberrations linked to breast cancer pathophysiologies. , 2006, Cancer cell.
[21] Guojun Wu,et al. Comprehensive analysis of oncogenic effects of PIK3CA mutations in human mammary epithelial cells , 2008, Breast Cancer Research and Treatment.
[22] A. Tomida,et al. A new evaluation method for quantifying PI3K activity by HTRF assay. , 2008, Biochemical and biophysical research communications.
[23] M. Lewis,et al. Regulated expression patterns of IRX-2, an Iroquois-class homeobox gene, in the human breast , 1999, Cell and Tissue Research.
[24] Andrew D. Yates,et al. A screen of the complete protein kinase gene family identifies diverse patterns of somatic mutations in human breast cancer , 2005, Nature Genetics.
[25] A. Marchetti,et al. Different Prognostic Roles of Mutations in the Helical and Kinase Domains of the PIK3CA Gene in Breast Carcinomas , 2007, Clinical Cancer Research.
[26] G. Parmigiani,et al. The Consensus Coding Sequences of Human Breast and Colorectal Cancers , 2006, Science.
[27] C. Glass,et al. TBL1 and TBLR1 phosphorylation on regulated gene promoters overcomes dual CtBP and NCoR/SMRT transcriptional repression checkpoints. , 2008, Molecular cell.
[28] Joel Greshock,et al. High resolution genomic analysis of sporadic breast cancer using array-based comparative genomic hybridization , 2005, Breast Cancer Research.
[29] P. Hall,et al. An expression signature for p53 status in human breast cancer predicts mutation status, transcriptional effects, and patient survival. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[30] Y. Maeda,et al. The prepattern transcription factor Irx2, a target of the FGF8/MAP kinase cascade, is involved in cerebellum formation , 2004, Nature Neuroscience.